Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer.

Arnedos, M; Scott, V; Job, B; De La Cruz, J; Commo, F; Mathieu, M C; Wolp-Diniz, R; Richon, C; Campone, M; Bachelot, T; Dalenc, F; Dessen, P; Lacroix, L; Lazar, V; Soria, J C; Delaloge, S; Andre, F

Arnedos, M; Scott, V; Job, B; De La Cruz, J; Commo, F; Mathieu, M C; Wolp-Diniz, R; Richon, C; Campone, M; Bachelot, T; Dalenc, F; Dessen, P; Lacroix, L; Lazar, V; Soria, J C; Delaloge, S; Andre, F.

Affiliation

Arnedos M; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.

Eur J Cancer ; 48(15): 2293-9, 2012 Oct.

Article in En | MEDLINE | ID: mdl-22840369

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Phosphatidylinositol 3-Kinases / Proto-Oncogene Proteins c-akt / Mutation Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Eur J Cancer Year: 2012 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google